-
Efficacy and safety of PRRT for the treatment of pancreatic neuroendocrine tumors: Systematic review and meta-analysi
Author: Zhao, Jun; Pei, Xiaxia; Li, Yumin
Journal: BULLETIN DU CANCER. 2026; Vol. 113, Issue 3, pp. 343-351. DOI: 10.1016/j.bulcan.2025.10.001
-
MARVELD1 inhibits Neuro2a cell migration and tumorigenesis via regulating the transcriptional coactivators and protein methylatio
Author: Liu, Weizhe; Dong, Yucui; Guo, Ruiying; Zhou, Dingyan; Qin, Yiping; Ma, Yuetao; Zhang, Juanjuan; Li, Aiying
Journal: BULLETIN DU CANCER. 2025; Vol. 112, Issue 5, pp. 458-468. DOI: 10.1016/j.bulcan.2025.01.010
-
Research progress on the role and molecular mechanism of PRDX4 in malignant tumor
Author: Li, Xuelian; Ma, Lilong; Shang, Panfeng
Journal: BULLETIN DU CANCER. 2025; Vol. 112, Issue 5, pp. 519-526. DOI: 10.1016/j.bulcan.2025.02.009
-
Long non-coding RNA BCAR4 regulates osteosarcoma progression by targeting microRNA-1260
Author: Pan, Yixin; Tang, Xiaolei; Xie, Yadong; Zhang, Huamin; Huang, Ziyu; Huang, Changjia
Journal: BULLETIN DU CANCER. 2025; Vol. 112, Issue 4, pp. 375-386. DOI: 10.1016/j.bulcan.2024.09.003
